These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38529478)

  • 1. Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease.
    Xian M; Xu J; Zheng Y; Zhang L; Zhao J; Chen J; Li S; Lin L; Zhong Y; Yang Z; Xie T; Huang L; Ding Y
    Int J Chron Obstruct Pulmon Dis; 2024; 19():799-813. PubMed ID: 38529478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification.
    Qinjun Y; Dandan Y; Hui W; Yating G; Xinheng W; Di WU; Jiabing T; Chuanbo W; Zegeng LI
    J Tradit Chin Med; 2024 Aug; 44(4):770-783. PubMed ID: 39066538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.
    Wu L; Chen Y; Yi J; Zhuang Y; Cui L; Ye C
    Biomed Res Int; 2020; 2020():9105972. PubMed ID: 33313323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of Jianpiyifei II granules in the treatment of chronic obstructive pulmonary disease: Network pharmacology analysis, molecular docking, and experimental assessment.
    Xie D; Quan J; Yu X; Liang Z; Chen Y; Wu L; Lin L; Fan L
    Phytomedicine; 2024 Apr; 126():155273. PubMed ID: 38342020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration the mechanism of Shenling Baizhu San in the treatment of chronic obstructive pulmonary disease based on UPLC-Q-TOF-MS/MS, network pharmacology and in vitro experimental verification.
    Gao Z; Wang J; Lu G; Wu Q; Wang S; Wu X; Ou C; Wu Z; Yu H; Wang Y
    J Ethnopharmacol; 2024 Apr; 324():117728. PubMed ID: 38216101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the potential mechanism and therapeutic targets of Cangzhu Erchen decoction for the treatment of chronic obstructive pulmonary disease based on bioinformatics and network pharmacology.
    Gu X; Ju J; Chen Q; Ge M; Huang H
    Medicine (Baltimore); 2024 Aug; 103(33):e39338. PubMed ID: 39151493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking.
    Yu X; Qin W; Cai H; Ren C; Huang S; Lin X; Tang L; Shan Z; Al-Ameer WHA; Wang L; Yan H; Chen M
    Comput Biol Med; 2024 Feb; 169():107863. PubMed ID: 38199208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the Potential Mechanisms of Compounds from Rheum palmatum L. against Chronic Obstructive Pulmonary Disease: A Network Pharmacology Study.
    Xue J; Shi S
    Comb Chem High Throughput Screen; 2021; 24(7):1093-1113. PubMed ID: 32875982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.
    Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety evaluation of Tibetan medicine Qishiwei Zhenzhu Pills based on serum pharmacochemistry and network pharmacology].
    Yan ZY; Zong YH; Zhang CF; Wu LL; Qin LL; Liu TH
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2538-2551. PubMed ID: 37282883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology prediction and molecular docking analysis reveal the mechanism of modified Bushen Yiqi formulas on chronic obstructive pulmonary disease.
    Choi W; Wu Y; Li Y; Dong J
    J Gene Med; 2024 Jan; 26(1):e3607. PubMed ID: 37795773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the molecular mechanism of Nux Vomica in treating ischemic stroke using network pharmacology and molecular docking methods.
    Zhang C; Gai J; Fan X; Lei J; Tang J
    Medicine (Baltimore); 2023 Apr; 102(16):e33625. PubMed ID: 37083769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation.
    Pan J; Tang J; Gai J; Jin Y; Tang B; Fan X
    Medicine (Baltimore); 2023 May; 102(21):e33877. PubMed ID: 37233418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
    Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
    J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on mechanism of Rehmanniae Radix Praeparata for treatment of osteoarthritis based on network pharmacology and molecular docking].
    Feng WQ; Liu KY; Zhang JN; Li YZ; Liu JL; Lu JQ; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5336-5343. PubMed ID: 36472041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the Bushen Huoxue formula in the treatment of osteoarthritis based on network pharmacology-molecular targets.
    Pang T; Liu C; Yao J; Li J; Li Z; Lou H; Lei S; Zhang J; Dong L; Wang Y
    Medicine (Baltimore); 2022 Aug; 101(32):e29345. PubMed ID: 35960090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury.
    Wang Y; Chen X; Wang Y; Zhong H; Liu L; Ye Y
    Medicine (Baltimore); 2023 Dec; 102(48):e36349. PubMed ID: 38050247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.